Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Buti

Showing results (131-140 of 336) with videos related to

Pageof 34
Sort By:
The Oncologist|July 28, 2025
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental SurveyMarina Campione, Michele Maffezzoli, Aruni Ghose, et al.
Translational Pediatrics|April 9, 2024
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case reportYunlong Zhang, Changchun Li, Xiaobin Deng, et al.
Tumori|May 5, 2010
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimenGianluca Tomasello, Matteo Dalla Chiesa, Sebastiano Buti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) studySebastiano Buti, Silvia Lazzarelli, Matteo Dalla Chiesa, et al.
Biomedicines|October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell CarcinomaMartina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and CryoablationLorenzo Bertolotti, Federica Segato, Francesco Pagnini, et al.
Clinical Medicine Insights. Oncology|September 16, 2021
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective StudySebastiano Buti, Fabiana Perrone, Teresa Zielli, et al.
European Urology Oncology|July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Clinical Genitourinary Cancer|June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World PopulationGiorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Biomed Research International|June 11, 2019
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single BiomarkerDiego Signorelli, Patrizia Giannatempo, Giulia Grazia, et al.
Pageof 34

Showing results (131-140 of 336) with videos related to

Sort By:
Pageof 34
The Oncologist|July 28, 2025
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental SurveyMarina Campione, Michele Maffezzoli, Aruni Ghose, et al.
Translational Pediatrics|April 9, 2024
Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case reportYunlong Zhang, Changchun Li, Xiaobin Deng, et al.
Tumori|May 5, 2010
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimenGianluca Tomasello, Matteo Dalla Chiesa, Sebastiano Buti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) studySebastiano Buti, Silvia Lazzarelli, Matteo Dalla Chiesa, et al.
Biomedicines|October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell CarcinomaMartina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
Diagnostics (Basel, Switzerland)|October 14, 2023
Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and CryoablationLorenzo Bertolotti, Federica Segato, Francesco Pagnini, et al.
Clinical Medicine Insights. Oncology|September 16, 2021
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective StudySebastiano Buti, Fabiana Perrone, Teresa Zielli, et al.
European Urology Oncology|July 24, 2019
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?Melissa Bersanelli, Roberto Iacovelli, Sebastiano Buti, et al.
Clinical Genitourinary Cancer|June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World PopulationGiorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Biomed Research International|June 11, 2019
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single BiomarkerDiego Signorelli, Patrizia Giannatempo, Giulia Grazia, et al.
Pageof 34